跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TUG-891
首页
药物
TUG-891
TUG-891
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of FFAR4 agonist in preparation of medicine for treating lung adenocarcinoma
CN 120754075 A
申请人: THE FIRST AFFILIATED HOSPITAL OF NINGBO UNIV
优先权: 2025
CN
Application of GPR120/FFAR4 agonist TUG-891 in preparation of medicine for treating diabetes and periodontitis syndrome
CN 121370857 A
申请人: STOMATOLOGY HOSPITAL ZHEJIANG UNIV SCHOOL OF MEDICINE
优先权: 2025
CN
Application of free fatty acid receptor 4 agonist in preparation of medicine for treating and/or preventing depression and medicine composition
CN 122376748 A
申请人: UNIV CHINA PHARMA
优先权: 2026
CN
药物
反馈